Live feed21:33:51·4hINSIDERFilingvia QuantisnowEVP, Head of R&D & CMO Inrig Jula exercised 32,395 shares at a strike of $8.93 and sold $2,785,021 worth of shares (44,674 units at $62.34) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 100,491 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TVTX· Travere Therapeutics Inc.Health CareOriginal source